Skip to main content

Blog

Duchenne Secures $12.5 Million in CDMRP Funding for FY25: A Hard-Fought Victory in a Challenging Year

...

A Safety Update on ELEVIDYS

...

Key Updates from the 2025 MDA Clinical & Scientific Conference

...

WATCH: Capricor Therapeutics – Update on Deramiocel for Cardiomyopathy in Patients with Duchenne (Webinar Recording)

...

Avidity Biosciences Announces Positive Topline Del-zota Data in Phase 1/2 EXPLORE44® Trial

...

The Impact of the Continuing Resolution and Federal Budget Cuts to the CDMRP on Duchenne Research

...

PPMD Hosts Duchenne Early Intervention Symposium

...

Advocates Unite in Washington D.C. to Champion Duchenne Policy Reforms

...

Capricor Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application for Deramiocel

...

WATCH: Solid Biosciences – Update on Gene Therapy Candidate SGT-003 (Webinar Recording)

...